Article Text

PDF
Research
The 2015 upper gastrointestinal “Be Clear on Cancer” campaign: its impact on gastroenterology services and malignant and premalignant diagnoses
  1. Keith Siau1,
  2. Andrew Chong Yew2,
  3. Samantha Hingley1,
  4. James Rees3,
  5. Nigel John Trudgill3,
  6. Andrew M Veitch2,
  7. Neil C Fisher1
  1. 1Department of Gastroenterology, Russell’s Hall Hospital, Dudley, UK
  2. 2Department of Gastroenterology, New Cross Hospital, Wolverhampton, UK
  3. 3Department of Gastroenterology, Sandwell and West Birmingham Hospitals NHS Trust, Lyndon, West Bromwich, UK
  1. Correspondence to Dr Keith Siau, Department of Gastroenterology, Russell’s Hall Hospital, Pensnett Road, Dudley, DY1 2HQ, UK; keith{at}siau.org

Abstract

Objective To assess the impact of the upper gastrointestinal ‘Be Clear on Cancer’ campaign launched by Public Health England between January and February 2015 on open-access gastroscopy referrals, incidence of target diagnoses (oesophagogastric cancer and Barrett’s oesophagus), cancer staging at presentation, 1-year survival and cost per additional diagnosis.

Design We performed a retrospective study of patients referred for 2-week-wait (2WW), open-access endoscopy 3 months following the campaign with diagnoses, endoscopic findings, staging and 12-month survival compared with data from corresponding months in 2014.

Setting Three adjacent National Health Service trusts in the West Midlands with a combined population of 1.34 million in 2015.

Results 2WW open-access referrals increased by 48% (95% CI 1.35 to 1.61, p<0.001). The proportion of target diagnoses fell from 6.7% to 6.1% (p=0.62). There were no significant overall increases in target diagnoses (OR 1.35, 95% CI 0.95 to 1.92, p=0.11) or cancer (OR 1.30, 95% CI 0.80 to 2.07, p=0.36). There was no change in tumour, node, metastasis (TNM) staging for oesophageal or gastric cancer. Overall 1-year survival did not alter significantly (HR 1.10, 95% CI 0.56 to 2.19, p=0.76).

Discussion The ‘Be Clear on Cancer’ campaign led to a 48% increase in demand for 2WW gastroscopies but did not significantly affect the incidence of target diagnoses, cancer staging or 1-year survival.

  • be clear on cancer
  • screening
  • upper gastrointestinal cancer
  • barrett’s oesophagus

Statistics from Altmetric.com

Footnotes

  • Contributors All authors contributed equally.

  • Competing interests None declared.

  • Patient consent No specific use of patients.

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • Correction notice This article has been corrected since it published Online First. The results in the abstract has been corrected.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.